Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020

SELL
$55.65 - $79.83 $218,426 - $313,332
-3,925 Closed
0 $0
Q3 2019

Oct 30, 2019

SELL
$64.7 - $85.39 $153,339 - $202,374
-2,370 Reduced 37.65%
3,925 $286,000
Q2 2019

Jul 23, 2019

BUY
$67.77 - $82.2 $426,612 - $517,449
6,295 New
6,295 $517,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.46B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.